Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial.
El-Shanshory M, Hablas NM, El-Tahlawi R, Awny S, Aboonq MS, Al Jaouni SK, Abdel-Latif TM, Abdel-Gawad AR, Okashah AM, Fakhreldin AR, Baghdadi H, El-Allaf H, Shebel Y, El-Sawy SA, Albeihany A, Mahmoud HS, Sayed AA, Abu-Elnaga MA, Nabo MMH, El-Dardear A, Abdel-Rahman IM, El Sayed SM, Mahmoud AA.
El-Shanshory M, et al.
Am J Blood Res. 2022 Aug 15;12(4):125-135. eCollection 2022.
Am J Blood Res. 2022.
PMID: 36147606
Free PMC article.